B. Sibley

Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.

M. Hegen, J. Keith, Paul W. Wu, 2007, Arthritis and rheumatism.

Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys

Y. Vugmeyster, A. Wahl, K. Mohler, 2011, Rheumatology.

Purification and characterization of other distinct bone-inducing factors.

V. Rosen, E. Wang, J. Wozney, 1988, Proceedings of the National Academy of Sciences of the United States of America.